News
Positive study results in Phase 2 lead to a green light for the companies’ combination and plans to move their nasal spray ...
Clinical Trials Arena on MSN22h
atai and Beckley Psytech’s psychedelic wins in Phase IIb depression trialThe companies are also running an open-label study to evaluate the long-term efficacy and safety of the therapy.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback